Debut Plus

₹81.09

▼ -3.48 -4.11%

As of 23 Oct 2026 · delayed

NSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-10-05
NSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-10-02

Bal Pharma Ltd. (BALPHARMA)

Volume: 18,242Avg Vol 1W: 15,116.8Avg Vol 1M: 36,117.852W Range:₹60₹124.6
NSE BSE www.balpharma.com AI Report
Key Ratios
Checked 21h ago
Market Cap₹129 Cr
Current Price₹81.09
Previous Close₹84.57
High / Low (52w)₹124.6 / ₹60
Volume18,242
Avg Vol (1W)15,116.8
Avg Vol (1M)36,117.8
Stock P/E17.9
Book Value₹51.65
Dividend Yield147%
ROE7.64%
ROA193.1%
Revenue (TTM)₹314 Cr
Revenue Growth-10.6%
Profit Margin215.3%
Total Debt₹31 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹4.53
P/B1.58
Debt / Equity1.94
50 DMA₹95.26
200 DMA₹82.58
Day change-4.11%
SurveillanceESM · ESM 1
Price Chart
₹81.09▼ 1.01% · 1Y
₹114₹607.8L
2025-10-27
2026-10-23

20-day avg volume: 36K shares

Pros
  • Pays a dividend yield of 147.0%.
  • Company is almost debt-free.
  • Revenue grew 31% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹74 Cr₹73 Cr₹82 Cr₹66 Cr₹74 Cr₹88 Cr₹84 Cr₹89 Cr
EBITDA₹5 Cr₹6 Cr₹7 Cr₹4 Cr₹5 Cr₹7 Cr₹7 Cr₹6 Cr
Net Profit₹1 Cr₹0 Cr₹5 Cr₹0 Cr₹1 Cr₹2 Cr₹4 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹305 Cr₹82 Cr₹66 Cr₹74 Cr₹87 Cr₹84 Cr₹314 Cr₹88 Cr
EBITDA₹22 Cr₹7 Cr₹4 Cr₹5 Cr₹7 Cr₹7 Cr₹23 Cr₹6 Cr
Net Profit₹7 Cr₹6 Cr₹0 Cr₹1 Cr₹2 Cr₹4 Cr₹6 Cr₹1 Cr
EPS4.56—————3.95—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹261 Cr₹238 Cr₹240 Cr₹261 Cr₹313 Cr₹320 Cr₹336 Cr₹376 Cr
Total Liabilities₹201 Cr₹193 Cr₹187 Cr₹202 Cr₹249 Cr₹248 Cr₹258 Cr₹293 Cr
Equity₹60 Cr₹45 Cr₹53 Cr₹58 Cr₹64 Cr₹72 Cr₹77 Cr₹82 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹10 Cr₹23 Cr₹22 Cr₹28 Cr₹-1 Cr₹27 Cr₹22 Cr₹31 Cr
Investing₹-8 Cr₹-5 Cr₹-6 Cr₹-9 Cr₹-22 Cr₹-19 Cr₹-15 Cr₹-21 Cr
Financing₹0 Cr₹-20 Cr₹-17 Cr₹-17 Cr₹24 Cr₹-1 Cr₹-8 Cr₹-10 Cr
Free Cash Flow₹10 Cr₹23 Cr₹22 Cr₹28 Cr₹-1 Cr₹27 Cr₹22 Cr₹31 Cr
Shareholding
Promoter 50.86% Institutions 0.28% Public 48.87%
Efficiency & Working Capital
ROCE9.2%
Interest Coverage1.4
Dividend Payout—
Debtor Days110 d
Inventory Days136 d
Payable Days104 d
Cash Conversion Cycle142 d
Working Capital Days246 d
Shareholding Details

As of 2026-09-30

Promoter50.9%
FII0.3%
DII0%
Institutions0.3%
Public48.9%
Promoter Pledge0%
No. of Shareholders15,241
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters51.2%51.2%51.2%50.9%50.9%50.9%50.9%50.9%50.9%50.9%50.9%50.9%
FIIs0.1%0.1%0.1%0.1%0.1%0.1%0.2%0.2%0.1%0.1%0.1%0.3%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public48.6%48.6%48.6%49%49%49%49%48.9%49%49%49%48.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders15,06014,77215,01416,00715,66715,72315,82615,77415,52015,21414,97415,241
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Shailesh SiroyaShareholding of Promoter and Promoter Group17.2%27,45,459
Micro Labs LimitedShareholding of Promoter and Promoter Group12.6%20,11,736
Anita SiroyaShareholding of Promoter and Promoter Group6.6%10,49,220
Ram Keshav MurthyPublic Shareholding3.3%5,27,600
Anand SuranaShareholding of Promoter and Promoter Group3.3%5,25,686
Chandraprakash Dheerajmal SiroyaShareholding of Promoter and Promoter Group3.1%4,86,420
Dilip SuranaShareholding of Promoter and Promoter Group3%4,74,994
Prakash Chandra JainPublic Shareholding2.9%4,60,103
Naresh D PPublic Shareholding1.9%3,00,000
Shreya MardiaPublic Shareholding1.9%3,00,000
Asha Tapidas DodhiaPublic Shareholding1.8%2,93,247
Archana SuranaShareholding of Promoter and Promoter Group1.8%2,84,996
Gautam Chand MehtaPublic Shareholding1.2%1,84,966
Monica SuranaShareholding of Promoter and Promoter Group1.1%1,79,909
Dilip Surana (huf)Shareholding of Promoter and Promoter Group1.1%1,69,995
Anita Chandraprakash SiroyaShareholding of Promoter and Promoter Group0.8%1,22,687
Jivi Dheerajmal SiroyaShareholding of Promoter and Promoter Group0.3%46,080
Shrenik SiroyaShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Shailesh SiroyaED / MD / Promoter2025
Himesh VirupakshayaE D & Wholetime Director2025
H S VenkateshIndependent Non Exe. Director2025
Nicola NeeladriIndependent Non Exe. Director2025
Jatish ShethIndependent Non Exe. Director2025
Ravindrakumar KothariIndependent Non Exe. Director2025
Abdul BasithCompany Sec. & Compli. Officer2025
Bheekamchand MukeshAdditional Director2025
Segments — Product
SegmentRevenueShare
manufacturing and marketing of phar₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹105 Cr46.5%
Other than India₹121 Cr53.5%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10251616
Corporate Actions
TypeDateValueRemark
dividend2026-09-17₹1.2 (12%)Final
forthcoming2026-09-17Dividend—
forthcoming2026-08-12Board Meetings—
dividend2025-09-18₹1.2 (12%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025100348
2025000000
2025000314
Insider / Designated-Person Trades

5 recent disclosure(s)

SHAILESH SIROYAAcquisition · 7,50,000
MICRO LABS LIMITED RevisedAcquisition · 3,00,900
MICRO LABS LIMITED RevisedAcquisition · 3,00,900
MICRO LABS LIMITEDAcquisition · 4,00,000
MICRO LABS LIMITEDAcquisition · 3,00,900
Substantial Acquisitions (SAST)

3 disclosure(s)

Pref. Allotment13/04/2022 · 7,50,000
Market23/11/2021 · 4,00,000
Market27/08/2021 · 3,00,900
Company Information
Incorporated1987
AuditorSSJNB & Co
Investor Email[email protected]
🌐 www.balpharma.com ↗

📍 21 & 22 Bommasandra Indl Area, Hosur Road, Bangalore, Karnataka, 560092

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Balaji Amines LimitedBalaxi Pharmaceuticals Ltd.Solve Plastic Products LimitedBalkrishna Paper Mills LimitedBalkrishna Industries Ltd.Balmer Lawrie & Company Ltd.Balrampur Chini Mills Ltd.Balu Forge IndustriesBanaras Beads Ltd.Bannari Amman Sugars Ltd.Banco Products (India) Ltd.Bandhan Bank LimitedAll “B” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search